Skip to content

Addiction: all studies

Page 360 of 855: studies 3,591 to 3,600 of 8,547, newest first. Back to the addiction overview

Research

Protocol for a pilot study assessing a virtual mindfulness intervention for postpartum African American women.

Brain Behavior and Immunity Integrative April 1, 2024 Lindsey Garfield, Natalie N Watson-Singleton, Herbert L Mathews et al.

Elevated perinatal depressive symptoms are more common among disadvantaged African American women, and they are almost four times as likely to have postpartum posttraumatic stress compared to white women. For new mothers, depressive symptoms and posttraumatic stress can lead to negative parenting, poor mother-infant bonding, and delayed infant development. For African American women, a...

DOI: 10.1016/j.bbii.2024.100060 (opens in new tab) Full text (opens in new tab) Digital mindfulness Oxytocin Proinflammatory cytokines Psycho-behavioral symptoms

Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review

European Psychiatry April 1, 2024 N. Kabir, B. Anderson, Lisa Bouchet et al. 1 citation

Introduction Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and post-traumatic stress disorder. Objectives...

3,4-Methylenedioxymethamphetamine (MDMA) impairs cognitive function during withdrawal via activation of the arachidonic acid cascade in the hippocampus.

Drug and Alcohol Dependence April 1, 2024 Yoko Nawata, Tsuyoshi Nishioku, Tsuneyuki Yamamoto et al. 2 citations

The recreational drug ±3,4-methylenedioxymethamphetamine (MDMA; also known as "ecstasy") has unusual subjective prosocial and empathogenic effects, and has exhibited potential as an adjunct to psychotherapy in recent years. However, there has been some concern regarding possible neuropsychiatric symptoms, such as cognitive impairment and dependence, emerging after abstinence. Therefore, this...

DOI: 10.1016/j.drugalcdep.2024.111139 (opens in new tab) Full text (opens in new tab) MDMA Cognitive impairment Cyclooxygenase Prostaglandin e2 +4

Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala.

Neuropsychopharmacology April 1, 2024 Thomas J. Kelly, Emma M. Bonniwell, Lianwei Mu et al. 26 citations

Psychedelics such as psilocybin show great promise for the treatment of depression and PTSD, but their long duration of action poses practical limitations for patient access. 4-OH-DiPT is a fast-acting and shorter-lasting derivative of psilocybin. Here we characterized the pharmacological profile of 4-OH-DiPT and examined its impact on fear extinction learning as well as a potential mechanism...

DOI: 10.1038/s41386-023-01744-8 (opens in new tab) Full text (opens in new tab) Psychopharmacology Anxiety-treatment Fear-response Brain-chemistry

Spectroscopic behavior of bufotenine and bufotenine N-oxide: Solvent and pH effects and interaction with biomembrane models.

Biochimica et Biophysica Acta (BBA) - Biomembranes April 1, 2024 Gustavo Almeida E Silva, Vinícius Galvão Wakui, Lucília Kato et al. 2 citations

Bufotenine is a fluorescent analog of Dimethyltryptamine (DMT) that has been widely studied due to its psychedelic properties and biological activity. However, little is known about its spectroscopic properties in different media. Thus, we present in this work, for the first time, the spectroscopic behavior of bufotenine and bufotenine N-oxide by means of their fluorescence properties. Both...

DOI: 10.1016/j.bbamem.2024.184304 (opens in new tab) Full text (opens in new tab) Bufotenine Liposome Micelle Uv/visible spectroscopy +6

Self-Rated Effectiveness of Ayahuasca and Breathwork on Well-Being, Psychological Resilience, Self-Compassion, and Personality: An Observational Comparison Study

Psychoactives March 31, 2024 Rishma S. I. Khubsing, Martin van Leerdam, Eline Haijen et al. 3 citations

Background: In recent years, there has been a growing interest in the therapeutic potential of classical psychedelics like ayahuasca for mental health improvement. Naturalistic studies at ayahuasca retreats have shown (short-term) improvements in mental well-being but understanding the psychological mechanisms is crucial. We are interested in psychological processes such as resilience,...

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report.

Pharmaceuticals March 31, 2024 Maria Pepe, Marco Di Nicola, Fabrizio Cocciolillo et al. 6 citations

New Psychoactive Substances (NPS) are modifying the drug scenario worldwide and have become a public health concern because of their toxicological profiles and their harmful physical/psychological effects. 3-Methoxy-Phencyclidine (3-MeO-PCP), a non-competitive antagonist of glutamate N-methyl-D-aspartate (NMDA) receptors, belongs to the phencyclidine-like subfamily of arylcyclohexylamines and...

DOI: 10.3390/ph17040452 (opens in new tab) Full text (opens in new tab) 3-meo-pcp Nps Cognitive functioning Neuroimaging +1

Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort

Brain Sciences March 31, 2024 Gabriella Smedfors, Felicia Jennysdotter Olofsgård, Anna Steinberg et al. 4 citations

Background: Cluster headache (CH) is a debilitating condition, but current therapies leave CH patients in pain. The extent of this problem in Sweden is unknown. Methods: An anonymized questionnaire was sent to 479 Swedish CH patients to investigate patterns and perceived effects of treatments. Results: Three hundred fourteen answers were analyzed. The population was representative regarding age...

DOI: 10.3390/brainsci14040348 (opens in new tab) Abortive Illicit substances Preventive Medication side effects +4

Could the medicalization of psychedelics lead to the next generation of antidepressants?

The Biochemist March 28, 2024 Peter J. Duggan, S. Walker 1 citation

A major part of the counterculture that emerged in western societies in the 1960s centred around the use of mind-altering psychedelic drugs such as lysergic acid diethylamide (LSD). Humans had, however, been consuming hallucinogenic substances since prehistoric times and often incorporated them into their religious rituals. Concerns over the effects of potent psychedelics like LSD led to them...

Trauma Under Psychedelics: How Psychoactive Substances Impact Trauma Processing

bioRxiv Preprint Server March 28, 2024 Ophir Netzer, Noa Magal, Yonatan Stern et al. 7 citations preprint

Traumatic events play a causal role in the etiology of stress-related psychopathologies such as depression and posttraumatic stress disorder (PTSD). Recent research highlighted the therapeutic potential of psychoactive substances in alleviating trauma symptoms among chronic stress-related patients. This study is the first to investigate the impact of psychoactive substances consumed during...